{
    "2019-04-13": [
        [
            {
                "time": "",
                "original_text": "复星医药利润含金量远低于恒瑞",
                "features": {
                    "keywords": [
                        "复星医药",
                        "利润",
                        "含金量",
                        "恒瑞"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "估值550亿元“闯关”IPO 豪森药业上市梦再进一步",
                "features": {
                    "keywords": [
                        "估值",
                        "550亿元",
                        "IPO",
                        "豪森药业",
                        "上市"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}